HOOKIPA Pharma to Participate in the Van Lanschot Kempen Life Sciences Conference
NEW YORK and VIENNA, Austria, April 19, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced today that the company will participate in investor meetings at the Van Lanschot Kempen Life Sciences Conference being held in Amsterdam, April 25 – 26, 2023.
Related news for (HOOK)
- MoBot’s Stock Market Highlights – 05/01/25 03:00 PM
- HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
- 24/7 Market News Snapshot 10 January, 2025 – HOOKIPA Pharma Inc. Common Stock (NASDAQ:HOOK)
- Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
- Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
